Celltrion is a CMO/CDMO, Biopharmaceutical company company operating in the pharmaceutical industry.
A leading force in the Korean pharmaceutical industry, Celltrion achieved what was thought impossible by launching the world’s first antibody biosimilar from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plans to follow up by continuing its growth as a global biopharmaceutical company with unique approaches to small molecule pharmaceuticals and new businesses such as the Ubiquitous-healthcare platform business.
Company type
CMO/CDMO, Biopharmaceutical company
Products and services
Biopharmaceuticals, APIs (Active Pharmaceutical Ingredients)
Markets
North America (USA, Canada), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries)
Address
Celltrion, 13-6, Songdo-dong, Yeonsu-gu, Incheon, Korea, Republic of, 406-130
